Olon

#Manufacturing #Chemist Stand Side with Olon 📽 Watch the just released video interviews to our CEO Paolo Tubertini and VP Olon #Biotech Maurizio Sartorato to get an insight about the values and purposes of the recent acquisitions finalized by #Olon Group https://lnkd.in/dhsrkVfM. "We have acquired HuvePharma facility. The target is to enlarge our capabilities and production capacity. We'll reach more than 3000 cubic metres of total reaction capacity, being one the leading companies for capacity and size. This will be essential for our continuous growth" Paolo Tubertini

Pharma's Almanac David Alvaro Thanks for re launching the story!

Olon is ready to host productions in the new facility dedicated to ultra potent compounds We have successfully completed the installation and validation of the new Small Scale Production Area within the facility in Rodano (Milan); the installation of the plant for large-scale production will also be completed shortly, with completion scheduled for January 2025. The commercial-scale line will be fully integrated with the small-scale line. The new plant, fully designed to produce payloads, linker payloads, and ultra-potent APIs, is already ready to accommodate small-scale GMP production. In addition to being equipped with the most advanced systems to operate at the highest level of control, it has a dedicated quality control department and storage areas for active ingredients #API #HPAPI #activepharmaceuticalingredients #pharma #pharmasupplychain Read the full story here https://lnkd.in/dV9jpyUu

WE ARE HIRING! We are looking for a REGULATORY AFFAIRS PROFESSIONAL Check out this professional opportunity. In #Olon you can find a dynamic, constantly evolving work environment, open to creativity and personal contribution; an inclusive environment that fosters integration of different cultures and mindsets. Apply here https://lnkd.in/d2hWS78i Explore other opportunities here https://lnkd.in/eCtXQ_3d

From Olon to all our Indian Partners, HAPPY DIWALI!

Our BD experts will be attending #BioEurope in Stockholm next week! With more than 50 years experience in microbial fermentation, further than mammalian production, bioconjugation, F&F, Olon has developed extensive biotech know how including also High Potent or Toxic Compounds requiring high containment systems. We offer a wide range of expertise from small molecules to large molecules – peptides, enzymes, proteins Meet #Olon at Booth 158

Our partner Antheia, Inc., pharmaceutical ingredient manufacturer transforming essential medicine supply chains, has just announced that it has delivered its first commercial order of #thebaine to a leading pharmaceutical customer. Antheia has continued to produce thebaine at commercial scale with #Olon Andrea Conforto VP CDMO Biotech, comments “We are proud of the contribution we’ve given to this milestone. The partnership between Antheia and Olon is extremely important for the pharmaceutical environment and, overall, for patient’s access to treatments and for the global health. By using Antheia synthetic biology technology and Olon manufacturing asset and experience, we can produce sustainable and quality medicines, not being subject to a fragile and sometimes unpredictable supply chain of #API sourced from nature. As we are doing in the collaboration with Antheia, we can support pharma companies in developing, optimizing and manufacturing for our partners a wide range of molecules” Read the full story here https://lnkd.in/dw2WAP-6

World #ADC Summit will take place next week in San Diego. Come to #Olon booth 214 to meet personally Simona Tommasi, PhD Tim Morgan Fanny Goy Leveraging over four decades of expertise in containment for cytotoxic anticancer production, we stand at the forefront of #ADC payload, payload-linkers and #HPAPI manufacturing with unparalleled safety and efficiency

👨🔬 👩🔬 PEGS EUROPE IS JUST AROUND THE CORNER The Annual Protein & Antibody Engineering Summit is starting November 5th Let's connect in person with Enrico Zanetti and Melusine LARIVIERE and explore the countless opportunities of #Olon #CDMO relying on one the broadest biotech platform to develop and produce API https://lnkd.in/ge4ZTX5

We are pleased to announce the opening of the new state-of-the-art Development Lab-3 in #Olon Mahad (India) site, a cutting-edge facility. The new lab marks a significant milestone in our commitment to driving technological progress and delivering high-quality solutions to our clients and partners. It will not only enhance our internal R&D efforts but also serve as a platform for collaboration with external partners to meet growing demands of the pharmaceutical industry. We are working on the cutting edge of #R&D applied both to #chemistry, with flow chemistry, #photochemistry and #electrochemistry, and to #biotechnologies. High-level expertise and know-how applied to specific processes, consolidated in the 9 research centers, are connected, shared, and extensively applied across the whole of the group’s manufacturing network.